Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) Net Income towards Common Stockholders (2013 - 2026)

Updated

Regen BioPharma's Net Income towards Common Stockholders was -$637,785 in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$167,292 a year earlier.

Analysis

Regen BioPharma Inc (RGBP) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regen BioPharma's Net Income towards Common Stockholders was -$2.35 million through Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -$1.27 million.

  • In earlier fiscal years, Net Income towards Common Stockholders was -$668,255 in FY2024, $1.02 million in FY2023 (-54.0%), $2.23 million in FY2022 and -$6.77 million in FY2021.
  • Quarterly Net Income towards Common Stockholders has moved between -$67.08 million (fiscal Q2 2022) and $60.93 million (fiscal Q3 2022) over five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -637,785.00
Dec 31, 2025 -967,853.00
Sep 30, 2025 -572,469.00
Jun 30, 2025 -167,292.00
Mar 31, 2025 -19,354.00
Dec 31, 2024 -515,384.00
Sep 30, 2024 -65,902.00
Jun 30, 2024 -117,108.00
Mar 31, 2024 -122,454.00
Dec 31, 2023 -144,913.00
Sep 30, 2023 -280,242.00
Jun 30, 2023 -99,218.00
Mar 31, 2023 -54,978.00
Dec 31, 2022 1.45 Mn
Sep 30, 2022 -67,584.00
Jun 30, 2022 60.93 Mn
Mar 31, 2022 -67.08 Mn
Dec 31, 2021 2.39 Mn
Sep 30, 2021 -1.38 Mn
Jun 30, 2021 -7.49 Mn
API Access

Regen BioPharma Inc Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RGBP&period=max&api_key=YOUR_API_KEY